Wellington Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Wellington Management Group's VRTX Position: Q2 2026 in Review
Wellington Management Group increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, buying an estimated $15.5M and bringing the position to 3,247,658 shares worth $1.61B. The position accounts for 0.28% of the portfolio, ranked #84.
Wellington Management Group first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.66B in Q2 2023. 1,756 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Wellington Management Group held 3,247,658 shares of Vertex Pharmaceuticals worth $1.61B as of Q2 2026.
- Wellington Management Group bought 35,069 Vertex Pharmaceuticals shares in Q2 2026, an estimated $15.5M.
- Vertex Pharmaceuticals made up 0.28% of Wellington Management Group's portfolio in Q2 2026, its #84 holding.
- Wellington Management Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Wellington Management Group's Vertex Pharmaceuticals position peaked at $2.66B in Q2 2023.
- 1,756 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.